Klingman & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.81M | Buy |
|
|||||
|
2025
Q2 | $1.74M | Buy |
|
|||||
|
2025
Q1 | $1.56M | Buy |
|
|||||
|
2024
Q4 | $1.33M | Buy |
|
|||||
|
2024
Q3 | $1.47M | Buy |
|
|||||
|
2024
Q2 | $1.43M | Buy |
|
|||||
|
2024
Q1 | $1M | Buy |
|
|||||
|
2023
Q4 | $744K | Buy |
|
|||||
|
2023
Q3 | $666K | Sell |
|
|||||
|
2023
Q2 | $612K | Buy |
|
|||||
|
2023
Q1 | $374K | Buy |
|
|||||
|
2022
Q4 | $398K | Buy |
|
|||||
|
2022
Q3 | $343K | Buy |
|
|||||
|
2022
Q2 | $334K | Sell |
|
|||||
|
2022
Q1 | $312K | Buy |
|
|||||
|
2021
Q4 | $274K | Buy |
|
|||||
|
2021
Q3 | $223K | Buy |
|
|||||
|
2021
Q2 | $214K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $37K | Hold |
|
|||||
|
2016
Q2 | $36K | Hold |
|
|||||
|
2016
Q1 | $33K | Hold |
|
|||||
|
2015
Q4 | $39K | Hold |
|
|||||
|
2015
Q3 | $38K | Hold |
|
|||||
|
2015
Q2 | $39K | Buy |
|
|||||
|
2015
Q1 | $7K | Sell |
|
|||||
|
2014
Q4 | $20K | Buy |
|